Discovery could lead to more targeted lung cancer treatments

New findings from a study – funded in part by the Canadian Cancer Society – may lead to more targeted treatments for the thousands of Canadians diagnosed each year with non-small cell lung cancer (NSCLC), the most common type of this deadly disease. A team of researchers in Toronto discovered that the proteins found in lung tumours are dramatically different from those in normal lung tissue and can predict patient survival. Pinpointing which proteins are driving tumour growth could lead to individualized treatments which are better tailored to a patient’s cancer and could lead to improved survival. Read more here.